The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
about
Balancing high accrual and ethical recruitment in paediatric oncology: a qualitative study of the 'look and feel' of clinical trial discussions.Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001Cranial radiation for pediatric T-lineage acute lymphoblastic leukemia: a systematic review and meta-analysis.BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain.Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemiaThiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Machine learning applications for prediction of relapse in childhood acute lymphoblastic leukemia.Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003.Comparing doctors' and nurses' accounts of how they provide emotional care for parents of children with acute lymphoblastic leukaemia.Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients.Survival of childhood acute lymphoid leukaemia in Yorkshire by clinical trial era, 1990-2011.Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes.HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial.A remembrance: James B. Nachman 1948-2011.Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials.Using nonrandomized studies to inform complex clinical decisions: the thorny issue of cranial radiation therapy for T-cell acute lymphoblastic leukemia.Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor.The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial.Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.
P2860
Q30497244-0B79D221-A4C5-4EA9-9401-B20B578705E8Q33647130-2A0A3163-4C4B-4B5F-BFBC-01C79BABA5A7Q33647139-D22631C8-717E-4BE3-8E2D-872E58E9B8E8Q34203403-232EC178-9D90-4F47-B531-E537DE6CC5BCQ34358853-977C023B-4469-4E7D-8DFB-627D6DD35AB9Q35927146-EB5364D0-7A01-4293-9D44-BF0FAFFD671AQ36213239-B464C01B-781A-417A-8E42-496A6B3E70D4Q36532537-AD63F158-CBAD-431A-AF49-34E5DC586023Q37870055-99846CBC-31F9-4C19-AC4C-18A4AD0F5AF6Q38097334-D675874F-A295-424A-BBDA-D3611076BA68Q38636061-EE1E449F-0DF3-452A-AEC7-531902A8724EQ38909642-89FEB981-D441-4BA0-9655-C15AB5CB5713Q39700410-B65763D0-7A54-4BCB-A780-1754489636F5Q40598104-472902AD-816D-41A7-B10E-2AE5D6405320Q41692604-6AC1EBA8-7ECF-4E46-9FB2-2EF15EE1DA4FQ41728635-5F9D503F-C7A3-40D1-BB47-0D733FDF1BD4Q41813372-1CA8B818-9064-4ED5-A498-C062081DB4B3Q46189930-F2887950-A735-42EA-8799-70ED63708914Q47368648-1A3B62F5-80A1-4618-A8D2-4F7CF7C05554Q51000445-46BC0EE8-585B-411D-8F27-86948498A94DQ51026411-9CE263E3-249D-4D3F-9808-E994DE21BB87Q51515979-78BC742B-11EA-4AEF-B68A-9407BD4CA871Q52720511-7EF219A7-DE33-4865-9EA5-EE3A1C96B0B1
P2860
The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of risk stratificat ...... ncil trial ALL97 and ALL97/99.
@en
The impact of risk stratificat ...... ncil trial ALL97 and ALL97/99.
@nl
type
label
The impact of risk stratificat ...... ncil trial ALL97 and ALL97/99.
@en
The impact of risk stratificat ...... ncil trial ALL97 and ALL97/99.
@nl
prefLabel
The impact of risk stratificat ...... ncil trial ALL97 and ALL97/99.
@en
The impact of risk stratificat ...... ncil trial ALL97 and ALL97/99.
@nl
P2093
P1476
The impact of risk stratificat ...... ncil trial ALL97 and ALL97/99.
@en
P2093
Christopher Mitchell
Jeanette Payne
Rachel Wade
Sally Kinsey
Sue Richards
P304
P356
10.1111/J.1365-2141.2009.07769.X
P407
P577
2009-06-22T00:00:00Z